Ivantist Treats Glaucoma
Ivantis Microstent Technology
Ivantis MicroStent News & Events

The Hydrus Microstent Ivantis HYDRUS IV United States Clinical Trial

Contact Ivantis Microstent Developers

Within the United States the Food and Drug Administration (FDA) has approved the HYDRUS IV clinical trial, which is being conducted at leading cataract and glaucoma centers around the country. The HYDRUS IV clinical trial is now closed to enrollment. There were 556 patients treated as part of the HYDRUS IV Clinical Trial, making it the largest study of its kind in the micro-invasive glaucoma surgery (MIGS) area.